TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response

por López-Gómez, Carlos, Oliver-Martos, Begoña, Pinto-Medel, María-Jesús, Suardiaz, Margarita, Reyes-Garrido, Virginia, Urbaneja, Patricia, Fernández, Óscar, Leyva, Laura
Publicado 2016

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment

por Pinto-Medel, María Jesús, Oliver-Martos, Begoña, Urbaneja-Romero, Patricia, Hurtado-Guerrero, Isaac, Ortega-Pinazo, Jesús, Serrano-Castro, Pedro, Fernández, Óscar, Leyva, Laura
Publicado 2017

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß

por Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesús, Urbaneja, Patricia, Rodriguez- Bada, Jose Luis, León, Antonio, Guerrero, Miguel, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Publicado 2017

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway

por Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesus, Urbaneja, Patricia, Rodriguez-Bada, Jose Luis, Ortega-Pinazo, Jesús, Serrano, Pedro, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Publicado 2017

Skin Phototype Could Be a Risk Factor for Multiple Sclerosis

por Urbaneja, Patricia, Hurtado-Guerrero, Isaac, Hernández, Miguel Ángel, Oliver-Martos, Begoña, Oreja-Guevara, Celia, Ortega-Pinazo, Jesús, Alonso, Ana, Barón-López, Francisco J, Leyva, Laura, Fernández, Óscar, Pinto-Medel, María Jesús
Publicado 2020

Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients

por López-Gómez, Carlos, Pino-Ángeles, Almudena, Órpez-Zafra, Teresa, Pinto-Medel, María Jesús, Oliver-Martos, Begoña, Ortega-Pinazo, Jesús, Arnáiz, Carlos, Guijarro-Castro, Cristina, Varadé, Jezabel, Álvarez-Lafuente, Roberto, Urcelay, Elena, Sánchez-Jiménez, Francisca, Fernández, Óscar, Leyva, Laura
Publicado 2013

TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis

por López-Gómez, Carlos, Fernández, Óscar, García-León, Juan Antonio, Pinto-Medel, María Jesús, Oliver-Martos, Begoña, Ortega-Pinazo, Jesús, Suardíaz, Margarita, García-Trujillo, Lucía, Guijarro-Castro, Cristina, Benito-León, Julián, Prat, Isidro, Varadé, Jezabel, Álvarez-Lafuente, Roberto, Urcelay, Elena, Leyva, Laura
Publicado 2011

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

por Dominguez-Mozo, Maria Inmaculada, Perez-Perez, Silvia, Villar, Luisa María, Oliver-Martos, Begoña, Villarrubia, Noelia, Matesanz, Fuencisla, Costa-Frossard, Lucienne, Pinto-Medel, María Jesús, García-Sánchez, María Isabel, Ortega-Madueño, Isabel, Lopez-Lozano, Lorena, Garcia-Martinez, Angel, Izquierdo, Guillermo, Fernández, Óscar, Álvarez-Cermeño, Jose Carlos, Arroyo, Rafael, Alvarez-Lafuente, Roberto
Publicado 2020